2017
DOI: 10.1111/jdv.14344
|View full text |Cite
|
Sign up to set email alerts
|

A novel homozygous DOCK8 mutation associated with unusual coexistence of gross molluscum contagiosum and epidermodysplasia verruciformis in a DOCK8 deficiency patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 7 publications
2
5
0
Order By: Relevance
“…Furthermore, T cell function after CD3 stimulation (P3 and P5; Table S2) and B cell function as measured by antibody responses to common DNA and RNA viruses (P1–P5; Table S3) were normal. This finding is also consistent with those for patients with EVER2 deficiency (Crequer et al, 2013) but not for patients with RHOH, MST1, CORO1A, ARTEMIS, RASGRP, DOCK8, and TPP2 deficiencies who suffer from CD4 + T cell lymphopenia and various degrees of impairment of circulating T cell response to CD3 stimulation (Crequer et al, 2012a,b; Sanal et al, 2012; Stray-Pedersen et al, 2014; Stepensky et al, 2015; Tahiat et al, 2016; Liu et al, 2017; Platt et al, 2017). Finally, more detailed analyses of skin-homing T cell populations (CLA + , CCR10 + , CLA + CCR4 + , and CLA + CCR10 + subsets) revealed no frequency abnormalities in the five patients tested (P1–P4 and P15; Table S4), again contrasting with the smaller sizes of these subsets within the CD4 + compartment in RHOH-deficient patients (Table S4; Crequer et al, 2012b).…”
Section: Resultssupporting
confidence: 86%
See 2 more Smart Citations
“…Furthermore, T cell function after CD3 stimulation (P3 and P5; Table S2) and B cell function as measured by antibody responses to common DNA and RNA viruses (P1–P5; Table S3) were normal. This finding is also consistent with those for patients with EVER2 deficiency (Crequer et al, 2013) but not for patients with RHOH, MST1, CORO1A, ARTEMIS, RASGRP, DOCK8, and TPP2 deficiencies who suffer from CD4 + T cell lymphopenia and various degrees of impairment of circulating T cell response to CD3 stimulation (Crequer et al, 2012a,b; Sanal et al, 2012; Stray-Pedersen et al, 2014; Stepensky et al, 2015; Tahiat et al, 2016; Liu et al, 2017; Platt et al, 2017). Finally, more detailed analyses of skin-homing T cell populations (CLA + , CCR10 + , CLA + CCR4 + , and CLA + CCR10 + subsets) revealed no frequency abnormalities in the five patients tested (P1–P4 and P15; Table S4), again contrasting with the smaller sizes of these subsets within the CD4 + compartment in RHOH-deficient patients (Table S4; Crequer et al, 2012b).…”
Section: Resultssupporting
confidence: 86%
“…The clinical characteristics of EVER1- and EVER2-deficient patients (EV in the absence of other clinical manifestations; Orth, 2006, 2008; Burger and Itin, 2014) and of the patients with CIB1 deficiency described in this study are identical and markedly different from those of patients with atypical EV due to CD4 + T cell lymphopenia caused by RHOH, MST1 (encoded by STK4 ), CORO1A, ARTEMIS (encoded by DCLRE1C ), DOCK8, RASGRP1, LCK, and TPP2 deficiencies. In such patients, persistent β-HPV–induced lesions occur in the context of a much broader infectious, autoimmune, and tumoral phenotype (Crequer et al, 2012a,b; Sanal et al, 2012; Stray-Pedersen et al, 2014; Stepensky et al, 2015; Li et al, 2016; Tahiat et al, 2016; Liu et al, 2017; Platt et al, 2017). Consistent with this observation, the CIB1-deficient patients tested in this study had no detectable T-lymphocyte defects in terms of either cell numbers or functions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Inactivating mutations of RHOH ( Crequer et al, 2012b ) , STK4 (encoding the MST1 protein) ( Crequer et al, 2012a ), CORO1A ( Stray-Pedersen et al, 2014 ), DCLRE1C (encoding the Artemis protein) ( Tahiat et al, 2017 ), DOCK8 ( Sanal et al, 2012 ; Liu et al, 2017 ), RASGRP1 ( Platt et al, 2017 ), LCK ( Li et al, 2016 ), and TPP2 ( Stepensky et al, 2015 ) have been reported in patients with atypical EV. Interestingly, the clinical penetrance of these genetic disorders for EV lesions is low, as only a few patients present with manifestations of EV.…”
Section: Human Genetics Of Atypical Evmentioning
confidence: 99%
“…Recently, a limited number of patients with an EV-like phenotype have been described, namely, atypical EV. In contrast to typical EV patients, these patients not only suffer from EV-HPV-associated skin lesions but also co-infections with other viruses, bacteria, and fungi because of the T cell deficits caused by RHOH, IL7, MST1, CORO1A, TPP2, DCLRE1C, LCK, RASGRP1, and DOCK8 deficiencies (Crequer et al, 2012a,b;Stray-Pedersen et al, 2014;Horev et al, 2015;Stepensky et al, 2015;Li et al, 2016;Liu et al, 2017;Platt et al, 2017;Tahiat et al, 2017). More than 500 cases of typical EV have been described across different racial and ethnic groups, and several EV patients have been reported among the Chinese population; however, few of them have undergone detailed genetic analysis.…”
Section: Introductionmentioning
confidence: 99%